Haematologica (Feb 2024)

A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant

  • Ryotaro Nakamura,
  • Corinna La Rosa,
  • Dongyun Yang,
  • Joshua A. Hill,
  • Armin Rashidi,
  • Hannah Choe,
  • Qiao Zhou,
  • Chetan Raj Lingaraju,
  • Teodora Kaltcheva,
  • Jeffrey Longmate,
  • Jennifer Drake,
  • Cynthia Slape,
  • Lupe Duarte,
  • Monzr M. Al Malki,
  • Vinod A. Pullarkat,
  • Ahmed Aribi,
  • Steven Devine,
  • Michael R. Verneris,
  • Jeffrey S. Miller,
  • Stephen J. Forman,
  • Ibrahim Aldoss,
  • Don J. Diamond

DOI
https://doi.org/10.3324/haematol.2023.284544
Journal volume & issue
Vol. 109, no. 6

Abstract

Read online

No abstracts available.